ClassID:

93420

C07C311/06 - CPC Classification

Classification description:

Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Recent Application in this class:
#1
20260055122
2026-02-26

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

#2
20250332112
2025-10-30

IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES

#3
20250296915
2025-09-25

NOVEL AMINO ACID DERIVATIVES

#4
20240425447
2024-12-26

BENZOYLGLYCINE DERIVATIVES AND METHODS OF MAKING AND USING SAME

#5
20230312479
2023-10-05

NOVEL AMINO ACID DERIVATIVES

#6
20230063230
2023-03-02

NURR1 RECEPTOR MODULATORS

#7
20220356148
2022-11-10

ANTIVIRAL COMPOUNDS

#8
20220340604
2022-10-27

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

#9
20210206715
2021-07-08

Benzoylglycine derivatives and methods of making and using same

#10
20210047347
2021-02-18

Modulators of Sestrin-GATOR2 interaction and uses thereof

#11
20200079800
2020-03-12

Modulators of Sestrin-GATOR2 interaction and uses thereof

#12
20190367446
2019-12-05

Benzoylglycine derivatives and methods of making and using same

#13
20190225575
2019-07-25

Antiviral compounds

#14
20190169114
2019-06-06

Benzoylglycine derivatives and methods of making and using same

#15
20190077803
2019-03-14

TETRACYCLINE COMPOUNDS

#16
20190048029
2019-02-14

Modulators of sestrin-GATOR2 interaction and uses thereof

#17
20180099920
2018-04-12

Compounds for use in treating neuromuscular disorders

#18
20180072997
2018-03-15

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#19
20170129851
2017-05-11

Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

#20
20170114080
2017-04-27

Modulators of sestrin-GATOR2 interaction and uses thereof

#21
20170044160
2017-02-16

Tetracycline compounds

#22
20170020837
2017-01-26

FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE

#23
20160304441
2016-10-20

Benzamide derivatives useful in the treatment of muscular disorders and pain and for controlling spasticity and tremors

#24
20160070167
2016-03-10

Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, manufacturing method of electronic device, electronic device and compound

#25
20150239829
2015-08-27

Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

#26
20150105355
2015-04-16

4-dedimethylamino tetracycline compounds

#27
20140303384
2014-10-09

Phenicol antibacterials

#28
20140275093
2014-09-18

Substituted hydroxamic acids and uses thereof

#29
20140256701
2014-09-11

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#30
20120283201
2012-11-08

9-substituted minocycline compounds

#31
20120208850
2012-08-16

Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid

#32
20120202854
2012-08-09

4-substituted phenoxyphenylacetic acid derivatives

#33
20120149910
2012-06-14

Pesticidal carboxamides

#34
20120135968
2012-05-31

Tetracycline compounds

#35
20120083471
2012-04-05

Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same

#36
20120077796
2012-03-29

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#37
20110212969
2011-09-01

SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

#38
20110172174
2011-07-14

Antibacterial agents

#39
20110136792
2011-06-09

NOVEL CARBOXYLIC ACID ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS

#40
20110039802
2011-02-17

NPY Y5 ANTAGONIST

#41
20110039714
2011-02-17

Probes, Systems, and Methods for Drug Discovery

#42
20100324025
2010-12-23

Antibacterial agents

#43
20100292500
2010-11-18

NPY Y5 antagonist

#44
20100173955
2010-07-08

4-substituted phenoxyphenylacetic acid derivatives

#45
20100105905
2010-04-29

EP2 Agonists

#46
20100048590
2010-02-25

N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS

#47
20100010090
2010-01-14

AMPA receptor potentiators

#48
20090325962
2009-12-31

TYROSINE DERIVATIVE

#49
20090325908
2009-12-31

9-substituted minocycline compounds

#50
20090318703
2009-12-24

Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient

#51
20090306022
2009-12-10

7-substituted tetracycline compounds

#52
20090281085
2009-11-12

3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity

#53
20090247506
2009-10-01

Antibacterial agents

#54
20090215628
2009-08-27

Benzoyl-Substituted Alanines

#55
20090192096
2009-07-30

2′-substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them

#56
20090163496
2009-06-25

Antibacterial agents

#57
20090118169
2009-05-07

NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF

#58
20090036311
2009-02-05

Benzoyl-Substituted Alanines

#59
20090005433
2009-01-01

Fluorinated compounds

#60
20080275221
2008-11-06

Busulfan immunoassay

#61
20080269221
2008-10-30

Antibacterial agents

#62
20080249102
2008-10-09

HIV protease inhibitors

#63
20080167331
2008-07-10

Sulfonamides

#64
20080161401
2008-07-03

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

#65
20080045545
2008-02-21

EP2 agonists

#66
20070244197
2007-10-18

Antibacterial agents

#67
20070167635
2007-07-19

Cathepsin cysteine protease inhibitors

#68
20070155671
2007-07-05

Diaminopropionic acid derivatives

#69
20070142471
2007-06-21

Sulfonamides

#70
20070142230
2007-06-21

Benzoyl-substituted phenylalanineamides

#71
20070105914
2007-05-10

Substituted sulfonamides

#72
20070077608
2007-04-05

Busulfan immunoassay

#73
20070043090
2007-02-22

Sulfonamides

#74
20070015762
2007-01-18

NPY Y5 antagonist

#75
20070015755
2007-01-18

NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS

#76
20070010669
2007-01-11

Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#77
20070010536
2007-01-11

Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#78
20070004806
2007-01-04

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

#79
20060270710
2006-11-30

Methods for inhibition of angiogenesis

#80
20060258728
2006-11-16

Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient

#81
20060241129
2006-10-26

Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

#82
20060194817
2006-08-31

N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds

#83
20060189578
2006-08-24

Method for the synthesis of compounds of formula I and their uses thereof

#84
20060166866
2006-07-27

Cell adhesion inhibitors

#85
20060154988
2006-07-13

Antibacterial agents

#86
20060148760
2006-07-06

Method for the sysnthesis of compounds of formula I and their uses thereof

#87
20060089336
2006-04-27

4-Dedimethylamino tetracycline compounds

#88
20060069037
2006-03-30

Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors

#89
20060057656
2006-03-16

Busulfan immunoassay

#90
20060030599
2006-02-09

Sulphonamide derivatives

#91
20060030553
2006-02-09

Cell adhesion inhibitors

#92
20050245615
2005-11-03

Composition containing polyamine transport inhibitor and use thereof

#93
20050176828
2005-08-11

Hydrophobic polyamine analogs and methods for their use

#94
20050148473
2005-07-07

Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation

#95
20050107445
2005-05-19

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

#96
20050085515
2005-04-21

Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors

#97
20050080119
2005-04-14

Diaminopropionic acid derivatives

#98
20050009895
2005-01-13

3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors